Amgen price

$439.30$0.00 (--)
Last updated on Nov 22, 2026, 07:23:25.
Market cap
$235.64B
Circulating supply
--
All-time high
$475.02
24h volume
$0

About Amgen

Amgen Inc., established in 1980 and headquartered in Thousand Oaks, California, is a global biotechnology leader focused on discovering, developing, manufacturing, and delivering groundbreaking human medicines. The company's scientific endeavors span several critical therapeutic categories, including inflammatory conditions, oncology and hematology, bone health, cardiovascular diseases, nephrology, and neuroscience. Its extensive portfolio features a range of significant pharmaceutical products. Notable examples include Enbrel, prescribed for conditions like plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, which helps cancer patients by reducing the risk of infection linked to a low white blood cell count; Prolia, utilized in postmenopausal women to combat osteoporosis; and Xgeva, designed to prevent skeletal-related complications. Otezla offers relief for adult patients suffering from plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease. Aranesp addresses anemia and low red blood cell counts, while KYPROLIS is employed to treat patients with relapsed or refractory multiple myeloma. Furthermore, Repatha plays a vital role in lowering the incidence of major cardiovascular events such as myocardial infarction, stroke, and coronary revascularization. Amgen's comprehensive product lineup also encompasses Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. The company distributes its therapies worldwide, primarily serving healthcare providers, including physicians and their clinics, dialysis centers, hospitals, and pharmacies. Distribution is facilitated through pharmaceutical wholesale distributors, complemented by direct-to-consumer channels. Amgen actively engages in strategic collaborations. It has partnered with entities such as Novartis Pharma AG, UCB, Bayer HealthCare LLC, BeiGene, Ltd., Eli Lilly and Company, Datos Health, and Verastem, Inc., to jointly assess VS-6766 when combined with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. Another key alliance involves Kyowa Kirin Co., Ltd., for the co-development and commercialization of KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody targeting atopic dermatitis and other autoimmune conditions. Additionally, Amgen maintains research and development partnerships with Neumora Therapeutics, Inc. and Plexium, Inc.

Stock ticker
AMGN
Company
Amgen Inc.
Industry
Healthcare
Category
US
Stock split / reverse split
12
Launch date
Jun 17, 1983
Listed exchange
NASDAQ

Financials

Q3 FY2026 Earnings
Report period: Jul 1, 2026 – Sep 30, 2026

Summary: AMGN reported Revenue of 10.37B (+8.45%), beating expectations; EPS of 6.45 (+14.36%), beating expectations.

Revenue (USD)Beat10.37B+8.45%10.07B+12.28%297.15M+2.95%
EPS (USD)Beat6.45+14.36%5.79+15.33%0.66+11.39%
Financial estimates
● Actual● Estimate
Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
5.932.453.344.377.08
+13.60%+111.20%+4.37%+64.90%+19.39%
● EPS● YoY
Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
90.14B90.59B92.50B95.64B96.05B
80.52B81.93B83.31B83.95B81.70B
89.32%90.44%90.06%87.77%85.05%
● Assets● Liabilities● Ratio
Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
4.68B1.60B2.19B4.00B4.24B
+31.16%-66.41%+57.36%+75.52%-9.46%
● CFO● YoY

Shareholders

Shareholders
BLACKROCK, INC.9.14%
VANGUARD CAPITAL MANAGEMENT LLC6.52%
STATE STREET CORP5.65%
CAPITAL WORLD INVESTORS5.38%
INVESCO LTD.3.02%
Others70.26%
Institutions
% Owned85.56%+4.97%
Shares held462.03M+26.88M
Institutions3,250+12
% OwnedPrice
Name% OwnedChange
BLACKROCK, INC.9.14%+2.26M
VANGUARD CAPITAL MANAGEMENT LLC6.52%+235.87K
STATE STREET CORP5.65%+12.05K
CAPITAL WORLD INVESTORS5.38%-213.01K
INVESCO LTD.3.02%+5.01M

Dividends

Dividends
Last ex-dividend: Nov 20, 2026 Cash dividend: 2.52 USD per share
Dividend yield TTM
2.86%
Payout ratio LFY
66.90%
Frequency
Quarterly
20222023202420252026
7.768.529.009.5210.08
+2.73%+3.16%+3.22%+2.82%+2.31%
Dividend amount (USD)Dividend yield
Stock splits
Launch date: Jun 17, 1983
DateRatio
Nov 22, 19991 → 2
Mar 1, 19991 → 2
Aug 16, 19951 → 2
Sep 11, 19911 → 3
Aug 13, 19901 → 2
Trade on the go with the OKX app

Amgen’s recent prices

Past year----
3 months----
30 days----
7 days-5.79%$466.28

Amgen performance

$439.30
Amgen price today

Amgen price today is $439.30, marking a -- over the past 24 hours. On OKX, today’s Amgen trading volume reached --, worth over $0.00.

$475.02
Amgen all-time high

Amgen achieved its all-time high price of $475.02 on Nov 12, 2026. At today’s price of $439.30, Amgen price is now -7.52% lower than its historic high.

$439.30
Amgen in USD

The current Amgen to USD conversion rate is $439.30 per Amgen.

Guides

Find out how to buy Amgen

Getting started with crypto can feel overwhelming, but learning where and how to buy crypto is simpler than you might think. Kickstart your journey on the OKX mobile app, or right here on the web.

Dive in

Predict Amgen’s prices

How much will Amgen be worth over the next few years? Check out the community’s thoughts and make your predictions.

Forecast

View Amgen’s price history

Track your Amgen’s price history to monitor your holdings’ performance over time. You can easily view the open and close values, highs, lows, and trading volume using the table below.

Check it out

More to explore

Amgen FAQ

Amgen can offer strong returns, but is also subject to market volatility. Whether it’s a good investment depends on your risk tolerance, goals, and market conditions. Amgen’s price can be influenced by various factors such as adoption, regulation, technological advancement, and overall market sentiment. Always do your own research before buying Amgen and never buy more than you can afford to lose. This content is for informational purposes only and isn’t financial advice.

To buy Amgen at a low price, monitor the market closely and use tools like price alerts and technical indicators to keep you updated on price trends. Always do your own research and use secure platforms. This content is for informational purposes only and isn’t financial advice.

Depending on where you’re located, you can use bank transfer, credit/debit card, or Peer-to-Peer. Read our guide on how to use these different payment methods to buy Amgen xAMGN safely on a trusted exchange like OKX.

Currently, one Amgen is worth 439.3. For answers and insight into Amgen’s price action, you’re in the right place. Explore the latest Amgen charts and trade responsibly with OKX.

To read this Amgen price chart, hover over or click on the time period you want to view. Hover over the chart to view the corresponding price, displayed in your local currency.

Yes, Amgen’s price is updated in real-time on our Amgen price page. You can view the current price and historical price data here at all times.

Countries and regions differ on how digital assets transactions and holdings are taxed and how they view digital assets in general (money, property, commodity). In general, it is expected that you will pay capital gains tax when selling or swapping Amgen xAMGN. Refer here for a more detailed guide.

Staking and earning rewards with Amgen are subject to local restrictions. Log in or sign up to view products available in your country, region, or state of residence.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.